An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis Interventions: Drug: Baricitinib; Drug: Placebo Sponsors: Eli Lilly and Company; Eli Lilly and Company Recruiting - verified September 2013